Onco-Innovations Limited (NEOE: ONCO)
Health Care · Biotechnology · CA
CA$0.23
+12.50% today · -87.1% 1Y
Onco-Innovations Limited (NEOE: ONCO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.93M and employs 1 people.
Over the last twelve months the share price has lost 87.1%, trading between 0.20 and 1.83.
Tweenvest scores Onco-Innovations Limited across four factors: quality 48/100, value 50/100. Its strongest factor is value.
ONCO price history
Key figures
- Market cap
- $10.93M
- Revenue (TTM)
- $64.78K
- P/E
- -1.32
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 2.91
- 52-week high
- CA$1.83
- 52-week low
- CA$0.20
- Avg volume (3M)
- —
- Shares outstanding
- 69.22M
- Employees
- 1
- Next earnings
- —
About Onco-Innovations Limited
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.
- ISIN
- CA68237C1059
- Listed since
- Dec 31, 2024
- Exchange
- Aequitas Neo Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genomtec S.A.WSE: GMT | $11.13M | zł2.61 | -5.62% |
| Miro Sciences LtdASX: MSX | $11.09M | AU$0.04 | +2.44% |
| Chemomab Therapeutics Ltd.NasdaqCM: CMMB | $11.09M | $1.53 | +9.29% |
| Ceryvyn Therapeutics LimitedASX: CYV | $11.07M | AU$0.01 | +20.00% |
| Genomed Spólka AkcyjnaWSE: GEN | $10.92M | zł33.00 | -12.70% |
| TScan Therapeutics, Inc.NasdaqGM: TCRX | $10.89M | $0.16 | -4.40% |
| Verici Dx plcAIM: VRCI | $10.76M | £0.00 | 0.00% |
| TME Pharma N.V.ENXTPA: ALTME | $10.42M | €0.10 | -4.72% |